Enteral Feeding Devices Market worth over $7.8bn by 2027

Enteral Feeding Devices Market size is set to surpass USD 7.8 billion by 2027, according to a new research report by Global Market Insights Inc.
 

Growing geriatric population coupled with the shift towards the preference for home enteral therapy are the significant factors boosting the enteral feeding devices market growth. Increasing awareness among the patients regarding the availability of enteral feeding devices and the rising demand for reconstructive surgeries are some of the prominent factors driving the demand for enteral feeding devices. Rising in the adoption of enteral nutrition therapy, surge in the prevalence of chronic disorders, and rise in incidences of malnutrition cases are anticipated to aid in the upsurge of the industry size and fuel the market expansion in the coming years. Another factor propelling the industry growth is the high prevalence of premature births, surge in use of enteral nutrition for cancer patients, and the elderly population suffering from neurological ailments.
 

Growing demand for neonatal and preterm enteral feeding is poised to foster the enteral feeding devices market progression

Increasing demand for neonatal and preterm enteral feeding in hospitals will stimulate the industry expansion. The increase in preterm births is one of the prime factors augmenting the demand for enteral feeding devices to meet the nutritional needs of newborns. In addition, the rising prevalence of chronic diseases in infants is slated to drive the market value over the forecast period. Premature infants have high nutritional requirements and they commonly have medical issues that advance their metabolic energy needs comprising infection, hypoxia, and hypotension among others.
 

Higher safety, efficacy, and patient acceptability of enteral feeding pump is expected to spur the enteral feeding devices market revenue

Get more details on this report - Request Free Sample PDF
 

The enteral feeding pumps segment accounted for USD 1.28 billion in 2020 due to improving nutritional intake, preventing malnutrition, and addressing the greater mobility requirements of patients on longer-term enteral tube feeding. The enteral feeding pumps safety and efficacy have received increased interest in recent years as these devices are widely used across home and hospital settings. The rise in the cancer cases such as gastrointestinal cancer, liver cancer, and lung cancer across the globe is predicted to play a vital role in the high acceptance of enteral feeding pumps used to provide clinical nutrition to cancer patients. Moreover, the increasing number of malnutrition patients across the globe is influencing the preference for these devices.
 

Browse key industry insights spread across 300 pages with 432 market data tables & 17 figures & charts from the report, “Enteral Feeding Devices Market Size By Product (Enteral Feeding Tubes {Nasoenteric/Nasal Feeding Tube [Nasogastric Tube, Nasojejunal Tube], Abdominal/Ostotomy Feeding Tube [Gastrostomy Tube, Jejunostomy/Jejunal Tube, Gastrojejunal (GJ) or Transjejunal Tube]}, Enteral Feeding Pumps, Enteral Syringes, Giving Sets, Accessories), By Patient (Adult, Pediatric), By Application (Cancer {Head and Neck Cancer, Gastrointestinal Cancer}, Central Nervous System (CNS) & Mental Health, Non-malignant Gastrointestinal (GI) Disorders), By End-use (Home Care, Hospitals), COVID-19 Impact Analysis, Regional Outlook, Application Development Potential, Competitive Market Share & Forecast, 2021 – 2027” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/enteral-feeding-devices-market
 

Increase in the number of malnourished children across the globe will expand the existing customer pool

The pediatric segment in the enteral feeding devices market accounted for USD 2.05 billion in 2020 led by the complications of enteral feeding and the high prevalence of preterm births. Enteral nutrition is effective in ensuring the nutritional requirements and the growth of infants and children. Hence, enteral nutrition is used for children that are unable to eat, malnourished, or lack dietary measures which are inadequate to fulfill nutritional needs.
 

Growing concerns related to chronic diseases will push the demand for enteral feeding devices

The enteral feeding devices market for non-malignant gastrointestinal (GI) disorders segment was valued at USD 546 million in 2020 impelled by the rising geriatric population suffering from chronic ailments related to non-malignant gastrointestinal (GI) disorders such as constipation, intestinal obstruction, and inflammatory bowel disease among others. Gut health and nutrition are closely associated, hence enteral feeding devices have a direct impact on the quality of life and overall health of a patient. As per the article published in 2017, in the U.S., around 15 out of every 100 admissions for abdominal pain are attributed to small-bowel obstruction, with 300,000 admissions every year. Enteral feeding devices can be used for these patients to add nutritious substances or medications to the stomach. Furthermore, these devices play a major role in the management of critically ill patients with gut dysfunction. 
 

Rising number of hospitals offering nutritional support will drive the industry progression

The hospitals segment captured 38% of the enteral feeding devices market share in 2020 owing to the accessibility and development of user-friendly enteral feeding devices and the favourable reimbursement policies. The demand for these healthcare facilities is increasing credited to the high utilization rate of enteral feeding tools in hospitals and rising investment by government organizations in hospitals along with an increasing number of experienced and trained professionals. Additionally, the change in preference from parenteral nutrition to enteral nutrition has significantly impacted the industry revenue. The preference for enteral feeding in different post-operative issues is estimated to rise due to significant improvements in artificial nutrition in terms of adoption and usage, thereby increasing the usage of these devices in hospitals.
 

Increasing incidence of preterm birth in China is projected to fuel the industry value

China held a significant revenue share in the Asia Pacific enteral feeding devices market and is expected to expand at 8.1% growth rate through 2027 on account of the growing prevalence of chronic disorder and the rising incidence of preterm births. As per the article published in 2018, in China, the incidence of preterm birth was around 7.3 per 100 births. The major risk factors associated with these preterm births are maternal pre-existing diseases, hypertensive disorders in pregnancy, or sexually transmitted disease.
 

According to the Global Cancer Observatory, in China, in 2018, about 4,285,033 new cancer cases were diagnosed. The rising prevalence of lifestyle disorders and other diseases including autism and diabetes would propel the demand for enteral feeding instruments in the country. The rising geriatric population prone to chronic disorders that result in a number of ailments such as neurological disorders, digestive disorders, and organ failure among others are also one of the significant factors for such devices in the country. Moreover, the presence of prominent leaders in China will further amplify the market growth over the forecast period.
 

Players are emphasizing on strategic initiatives and innovative product launch to expand business operations

Some of the major companies operating in the enteral feeding devices market are ALCOR Scientific, Abbott Nutrition, Moog, Fresenius Kabi, ConMed, Cardinal Health, Becton Dickinson, B. Braun Melsungen, Vygon, Boston Scientific, Cook Medical, and Applied Medical Technologies among others. These participants are engaged in strategic collaborations, partnerships and agreements to gain competitive advantage over their competitors.